1st Breton participation at Medica
-
Upload
bretagnecommerceinternational -
Category
Business
-
view
543 -
download
3
Transcript of 1st Breton participation at Medica
16>19 November 2015
Exhibitors & visitors listHalls 3 - 5 - 8 - 17
MEDICA & COMPAMED Düsseldorf, Germany
France - Bretagne Pavilions
EXHIBITORS
BA HEALTHCARE
EUROCELL DIAGNOSTICS
LE GUELLEC TUBES & PROFILES
MENSIA TECHNOLOGIES
NG BIOTECH
NOWAK MEDICAL
VISITORS
VOXYGEN
ACCOMPANIED BY
BRETAGNE COMMERCE INTERNATIONAL
Stand
HALL 05 / M30-G
HALL 03 / H64-B
HALL 08B / F10-A
HALL 17 / B24-F
HALL 03 / H74-H
HALL 08B / G08-A
Page
4
5
6
7
8
9
10
11
Index of Companies
2
Floor PlanFranceBretagnePavilions
CME
CONFERENCETIONEDUCAATION
CONFERENCETS+ SPOR
MEDICINE
CONFERENCES//ONFERENZENK
CONFERENCEA MEDICINE + SPORTSMEDIC
South/CCD Süd
CONFERENCEAA EDUCMEDIC
South, /CCD Süd
PHYSIOA PHYSIO CONFERENCEMEDIC
South/CCD Süd
CONFERENCES
A MEDICINE + SPORTSSouth
TIONAonavillPCCD South,
A PHYSIO CONFERENCESouth
KRANKENHAUSTDEUTSCHER
tEas/tCCD Os
ARY AND MILIT TARY MEDICINECONFERENCE ON DISASTERDiMiMED – INTERNA
South/CCD Süd
CONFERENCE A PHYSIO CONFERENCEMEDIC
CONFERENCEEUROPEAN HOSPIT
tEas/tCCD Os
GASTA
ARY MEDICINECONFERENCE ON DISASTER
TIONALDiMiMED – INTERNASouth
A PHYSIO CONFERENCE
AL OSPIT A
3
Bedarfs- und VHalls 5, 6, 7.0, 7.1, 7a/enHall
apyPhysiotherapiePhysiother
Halls /enHall
ory equipment, diagnosatLaborechnik, DiagnosLabort
Halls 1, 2, 3/enHall
CHMESA FAMEDICC
el, auchsartikerbrBedarfs- und VHalls 5, 6, 7.0, 7.1, 7a
equipmentorthopaedic /apyechnikOrthopädiet/apie
54, Halls
ticsory equipment, diagnosaticechnik, Diagnos
Halls 1, 2, 3
AIRFTRADE //SECHMES
al equipment,HospitKommunikations
enhauseinrichtung,ankKr14Hall /eHall
echnolating toperomedicine, medicectrEl
echnik und EinrichtungOP-Tomedizin, MedizintektrEl
Halls /enHall
onsumer goods, tces, cDisposabl
xtilieneTBedarfs- und V
G
al equipment,emetsysKommunikations
enhauseinrichtung,14
ogy and equipmentechnol,ogyechnolal tomedicine, medic
echnik und Einrichtungechnik,omedizin, Medizint
14–9Halls
esxtileonsumer goods, tommodities andes, c
el, auchsartikerbrBedarfs- und V
National and intechnikMedizint
Gemeinschaftse und intNationalHalls 15, 16, 17/enHall
ogyechnoltormation and cInf
Kommunikationsormations- undInf
15Hall /eHall
ation sysommuniccal equipment,Hospit
ernational jointNational and intechnik
omedizin, ektrände, EltsGemeinschaftseernationale und int
Halls 15, 16, 17
ations ommunicormation and cechniktKommunikations
ormations- und15
emstation sysal equipment,
echnolal tmedicparticipants, el
O
ogyechnolomedicine,ectrparticipants, el
ORUMSF//OREN FAMEDIC
OUND CA WMEDIC6Hall /eHall
ORUMFTECH
A TECH FMEDIC12Hall /eHall
ORUMFTH ITHEALLTH IT
T A HEAL T MEDIC15Hall /eHall
ORUMARE FOUND C
ORUMA TECH F
ORUMTH IT F
T A HEAL T MEDIC
ORUMFECON
A ECON FMEDIC15Hall /eHall
ARE FTHCHEALA CONNECMEDIC
15Hall /eHall
ORUMTH IT F
ORUM by TKA ECON F
ORUMARE FTEDA CONNEC
Contact: Julien CaU
Hall 05 / M30-G
9 route de Chavagne35 310 MordellesFranCeTel.: +33 (0)2 99 85 11 [email protected]
BA HEALTHCARE key know-how is focused on designing,producing and deploying mobile wheel-basedautonomous platform for various applications.BA HEALTHCARE developed with GE Healthcare a specialAGV (Automated Guided Vehicle) that is embedded in afull solution for interventional radiography. The system,Discovery IGS, is commercialized by GE Healthcare.BA HEALTHCARE is leading other projects in the field ofrehabilitation robotics and people autonomy.One of them is a walk rehabilitation robot which is atherapeutic device. The second is a new device that willhelp elderly and/or disable people to stay home longer bygiving them more autonomy to move.BA HEALTHCARE is also willing to provide its expertise inprecise motion control and reliable autonomous roboticsto any healthcare project.
ROBO-K is a robot designed to reeducate patient withwalking deficiency from neurological origin, it includes amobile base allowing the patient to roam freely. Itoptimizes the therapeutic process by adapting constantlythe difficulty of the exercises according to the patient'sperformance. Session after session, ROBO-K optimizes therehabilitation process of walking and brings the patientto an ecological walk safely
4
BA Healthcare
Eurocell Diagnostics
Contact: Corinne BeThUel
Hall 03 / H64-B
19 rue louis delourmel35 230 noyal ChaTillon s/ seiChe
FranCeTel.: +33 (0)2 99 35 19 36
EUROCELL DIAGNOSTICS, a French company, was founded onDecember 2003 and its activity started on March 2004. Itsmission is to adapt and distribute, for the European clinicallaboratories, in vitro diagnostic products used in their DailyQuality Control.The company is bolstered by a contract of exclusive distributionin Europe for the hematology products manufactured by theAmerican company R&D Systems based in Minneapolis.EUROCELL DIAGNOSTICS offers a complete range of controlsand calibrators for hematology analyzers. EUROCELLDIAGNOSTICS is also the European authorized representativeof R&D Systems hematology products towards the DesignNational Authorities (DNA's) and particularly the French HealthProduct Safety Agency ANSM.In response to the implementation of European standards , thatcompels the laboratory to even more rigorous management inthe control of their quality, EUROCELL DIAGNOSTICS acts incomplete independence towards the instrument manufacturersand therefore fully complies with the European directives.
EUROCELL DIAGNOSTICSacting as a partner with R&D Systems,concerned of the quality of the products and services, assuresyou of:• Mono and multi-level packagings adapted to your needs• Deliveries on standing orders or on purchase orders• Pre-determined and reliable delivery schedule of activities• Rigorous technical assistance• Products and related servicing for all Hematologyinstruments• Interlaboratory Hematology Quality Control Program inconformity with Accreditation/Certification• Total independence and impartiality towards instrumentmanufacturers.
5
Contact: dominique GUiaVarCh
Hall 08b / F10-A
Zi de Pouldavid29 177 doUarneneZFranCeTel.: +33 (0)2 98 92 08 [email protected]
LE GUELLEC TUBES & PROFILES is specialized in theproduction of precision metal tubing and profilesfor medical applications (endoscopes, surgicalinstruments, laboratory equipment …).Our core business is the manufacture of small thintubes in Stainless Steel (316L, 316LVM, 904L, Phynox)and Nickel based alloys. Precision bars and otheralloys are also available on request.Diverse cutting, machining, bending & passivationcapabilities are also available in-house.
6
Le Guellec Tubes & Profiles
Mensia Technologies
Contact: Jean-yves QUenTel
Hall 17 / B24-F
Place du Granier35 571 ChanTePie cedex
FranCeTel.: +33 (0)1 57 27 47 26www.mensiatech.com
7
MENSIA TECHNOLOGIES is a Connected Health start-updeveloping ground-breaking non-invasive medicalsolutions leveraging the power of neuromodulation forthe care of the Central Nervous System (CNS). Non-invasive neuromodulation is a family of technologies,including neurofeedback, low-power electricity (TDCS), ormagnetic fields (rTMS). They induce a lastingnormalization of brain activity and have beendemonstrated to be an effective treatment for major CNSconditions. Our first product is an innovative, mobile, andpersonalized neurofeedback training (NFT) system for thetreatment of Attention Deficit Hyperactivity Disorder(ADHD). This medical device, ADHD@Home will provide analternative to symptomatic psychoactive medication likemethylphenidate (MPH). ADHD is a major Public Healthissue affecting 5% of children and a fast growingtherapeutics market estimated to reach $10B by 2020.
In June of 2015, we were awarded a multi-million euro grantby the European Union, under the highly competitiveH2020/SME Instrument program, to finalize our ADHDproduct and finance the required randomized clinical trial.This RCT is scheduled to start in Q2 of 2016 with theassistance of 10 centers in Europe (FR, NL, DE, SP …).
NG BIOTECH is a French company specialized in Research& Development, Manufacturing of Telediagnosticinnovative solutions.Founded by an experienced team of rapid In VitroDiagnostics pioneers and leaders in 2012, NG BIOTECH haspatented a platform allowing to develop real Quantitativeand Multiplex rapid tests. This technology is the base of anew generation of testing solutions which are adapted toreaders through unique algorithms. The company offers hand held readers allowing Mobility,Traceability and test results communication in real time.
NG BIOTECH innovates with a rapid pregnancy test onwhole blood for health care professionals. This test isperformed on 20µl of capillary blood, has a sensitivity of10mIU/mL and provides results in 5 minutes.NG-Test hCG WB is intended for urgent care rooms,hospitals, clinics and gynecology offices as well aspharmacists. This test allows the physician to take aquicker medical decision, to save current steps of bloodcollection, sample transport, centrifugation … and providesa higher level service to the patient.With its new patented quantitative and multiplex platformand its mobile reading instruments, NG BIOTECH bringsTelediagnostic innovations and applications in many fields.
Contact: Miguel rinCon
Hall 03 / H74-H
Za Courbouton - secteur 1 atelier relais le Tremplin35 480 GUiPryFranCeTel.: +33 (0)2 23 30 17 [email protected]
8
NG Biotech
Nowak Medical
Contact: isabelle BarJoU
Hall 08b / G08-A
Zone artisanale6 rue du Belier
35 320 PanCéFranCe
Tel.: +33 (0)2 99 43 01 97www.nowak.fr
9
NOWAK is a French high precision casting companylocated near Rennes (Bretagne). Since 1984, NOWAK hasbeen producing high precision castings to a wide sectorof activities.In 1997, NOWAK became parts of the Aalberts IndustriesGroup, thereby enhancing its development on theinternational scene.Specialized in cobalt alloys and stainless steel, NOWAKstarted in the early 2000’s the production of medicalparts (instruments and implants). Since then, over 70 000implants and ancillaries are produced annually.
As an OEM service provider for medical castings, NOWAKcombines process optimization and innovativemanagement to bring you high quality components at acompetitive cost thanks to its:• Established technical know-how: production ofcomplex castings thanks to the “lost wax” technologyand the rapid prototyping • Qualified staff and operators • Commitment to quality and excellence• Technical support: personalized advice andassistance during all the steps of your project • Flexible production capacity• Specialized tooling and equipment• Totally new medical facility dedicated to theproduction of medical parts• Certified ISO 13485 and ISO 9001 by the G-Med.
medical
Contact: Guillaume CUFFel
Visitor
Pôle Phoenix route du radôme22 560 PleUMeUr BodoUFranCeTel.: +33 (0)2 96 14 12 [email protected]
Spin off of a major telecom operator, VOXYGENprovidesspeech solutions, speech-to-text and text-to-speech invarious languages (French, English, American, German,Italian, Spanish, Arabic …). Associated with high-standard multi-expressive voices, it permit us to vocalizeany kind of textual information with the appropriateintonation in the right context. VOXYGEN offers a widerange of professional services (servers, embeddedsystems, cloud …) integrating custom voices creationand a large selection of voices and tongues.
VOXYGEN HEALTH is a newly created branch, dedicatedon new application and product developments forhealth purposes. The main idea is to providetechnological innovations based on VOXYGEN speechsynthesis knowledge, but also with non-invasive captorstreatment like breath, image or electrochemicalprocessing.
10
Voxygen
Bretagne Commerce International is anon-profit organization of privatecompanies located in Western France. Entrusted by the Regional Governmentof Bretagne and the Regional Chamberof Commerce to internationalize theBreton economy, it assists Bretoncompanies in their internationaldevelopment as well as foreigncompanies planning to invest inBretagne.Through customized and collectiveactivities, Bretagne CommerceInternational is committed to: E Raising awareness aboutinternational businessopportunities
E Supporting companies withadministrative issues
EHelping companies start and thenconsolidate their business.
Bretagne Commerce International
Contact: annie BerTheloT
le Colbert35 place du Colombier - Cs 71238
35 012 rennes cedex FranCe
Tel.: +33 (0)2 99 25 04 04Fax: +33 (0)2 99 25 04 00
www.BretagneCommerceinternational.comcontact@BretagneCommerceinternational.com
11
12
E From one of the founding countries of the European Union, you will be able toexpand on a market of 502 million consumers with a high purchasing power.
E Thanks to an outstandingly high level of initial education, you will benefit froma workforce which is able to adapt to the constant evolution of products andservices easily.
E Enjoying a high quality of life environment, you will find opportunities forinnovation, R&D and competitiveness, which is the evidence of great scientificand technological skills.
Why invest in Bretagne?
• 28,000 km²
• 3.25 million people(+23,000 inhab/year)
• €83,4 billion GdP
• 1st agri-Food regionin France
• 1st agriculturalregion in France
• 1st Fishing region
• 1st region forshipbuilding andrepair
• 1st region in Marinescience &Technology
• 1st region for filingof high Techeuropean patentsin France
• 2nd region fordigital r&d inFrance
land of excellence:
Digital, Automotive, Marine, Agriculture and Agri-Food
developing sectors:
Marine Renewable Energy, Green Vehicles, Eco-Activities, Biotech, Security & Defence
Bretagne plays host to almost 490 foreign companies
Bretagne economy: a snapshot
Bretagne and its strong industrial dynamics
13
Focus on HEALTHCARE SECTOR
• 2 universityhospitals (10,000 jobs)
• 198 public orprivatehealthcareestablishments
• 4 universities
• 20 “grandesécoles” (highereducationinstitutions)
• 9 technicalcenters
• 7 high-tech parks
• ID2Santé: theinnovation &technologytransfer center
A rich network
Expertise
e Medical technologies for diagnostics &therapeutics
e E-healthe Biotech & Pharmae Prevention & Health nutrition
Biotech in Bretagne
e #1 French region in Marine biotechnologye #3 French region in Biotechnologye 250 playerse 3 marine biology stations
25 research units dedicated to Health and 35 involved in Health research
+600 researchers
215 companies employing 8,000 persons
Bretagne, innovating for a more integrated managementof Health & Wellbeing
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
Note
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
........................................................................................................................
Note
Bretagne Commerce internationalle Colbert • 35 place du Colombier • Cs 71238 • 35012 rennes cedex • FranCe
Tel.: +33 (0)2 99 25 04 04 • Fax: +33 (0)2 99 25 04 [email protected]
www.BretagneCommerceinternational.com